Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × Olanzapine × 90 days × Clear all

NCT06554613 2026-05-05

Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung